Skip to main content
NCBI home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1975 Mar;2:286–297.

Patterns of presentation and relapse in the non-Hodgkin's lymphomata.

Z Fuks, E Glatstein, H S Kaplan
PMCID: PMC2149558  PMID: 1182073

Abstract

An analysis of the modes of distribution of initial sites of involvement in patients with Stage II and III non-Hodgkin's lymphoma revealed a contiguous pattern of involvement of lymph node bearing areas directly connected by lymphatic channels in 76% of patients with nodular lymphomata and in 84% of those with diffuse lymphomata. The patterns and frequencies of initial relapse following radiotherapy for each histopathological type and stage (Stage I-III) are described. The sites of relapse are analysed in relation to initial pretreatment sites of involvement and in relation to radiation fields employed. The therapeutic implications of these data are discussed.

Full text

PDF
286

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagley C. M., Jr, Devita V. T., Jr, Berard C. W., Canellos G. P. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann Intern Med. 1972 Feb;76(2):227–234. doi: 10.7326/0003-4819-76-2-227. [DOI] [PubMed] [Google Scholar]
  2. Banfi A., Bonadonna G., Carnevali G., Oldini C., Salvini E. Preferential sites of involvement and spread in maignant lymphomas. Eur J Cancer. 1968 Jul;4(3):319–324. doi: 10.1016/0014-2964(68)90058-3. [DOI] [PubMed] [Google Scholar]
  3. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  4. Chaffey J. T., Rosenthal D. S., Pinkus F., Hellman S. Advanced lymphosarcoma treated by total body irradiation. Br J Cancer Suppl. 1975 Mar;2:441–449. [PMC free article] [PubMed] [Google Scholar]
  5. Fuks Z., Kaplan H. S. Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology. 1973 Sep;108(3):675–684. doi: 10.1148/108.3.675. [DOI] [PubMed] [Google Scholar]
  6. GOWANS J. L., KNIGHT E. J. THE ROUTE OF RE-CIRCULATION OF LYMPHOCYTES IN THE RAT. Proc R Soc Lond B Biol Sci. 1964 Jan 14;159:257–282. doi: 10.1098/rspb.1964.0001. [DOI] [PubMed] [Google Scholar]
  7. HICKS E. B., RAPPAPORT H., WINTER W. J. Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer. 1956 Jul-Aug;9(4):792–821. doi: 10.1002/1097-0142(195607/08)9:4<792::aid-cncr2820090429>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  8. Han T., Stutzman L. Mode of spread in patients with localized malignant lymphoma. Arch Intern Med. 1967 Jul;120(1):1–7. [PubMed] [Google Scholar]
  9. Johnson R. E. Radiation therapy of generalized lymphocytic lymphomas. Am J Roentgenol Radium Ther Nucl Med. 1973 Jan;117(1):50–53. doi: 10.2214/ajr.117.1.50. [DOI] [PubMed] [Google Scholar]
  10. Jones S. E., Fuks Z., Bull M., Kadin M. E., Dorfman R. F., Kaplan H. S., Rosenberg S. A., Kim H. Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer. 1973 Apr;31(4):806–823. doi: 10.1002/1097-0142(197304)31:4<806::aid-cncr2820310408>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  11. Kaplan H. S. Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1221–1224. [PubMed] [Google Scholar]
  12. Page V., Gardner A., Karzmark C. J. Physical and dosimetric aspects of the radiotherapy of malignant lymphomas. I. The mantle technique. Radiology. 1970 Sep;96(3):609–618. doi: 10.1148/96.3.609. [DOI] [PubMed] [Google Scholar]
  13. Page V., Gardner A., Karzmark C. J. Physical and dosimetric aspects of the radiotherapy of malignant lymphomas. II. The inverted-Y technique. Radiology. 1970 Sep;96(3):619–626. doi: 10.1148/96.3.619. [DOI] [PubMed] [Google Scholar]
  14. Rosenberg S. A., Kaplan H. S. Hodgkin's disease and other malignant lymphomas. Calif Med. 1970 Oct;113(4):23–38. [PMC free article] [PubMed] [Google Scholar]
  15. Scott D. W., Howard J. C. Collaboration between thymus-derived and marrow-derived thoracic duct lymphocytes in the hemolysin response of the rat. Cell Immunol. 1972 Mar;3(3):430–441. doi: 10.1016/0008-8749(72)90248-1. [DOI] [PubMed] [Google Scholar]
  16. Spittle M. F., Harmer C. L., Cassady J. R., Kaplan H. S. Analysis of primary relapses after radiotherapy in Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:497–508. [PubMed] [Google Scholar]
  17. Stobo J. D., Paul W. E. Functional heterogeneity of murine lymphoid cells. 3. Differential responsiveness of T cells to phytohemagglutinin and concanavalin A as a probe for T cell subsets. J Immunol. 1973 Feb;110(2):362–375. [PubMed] [Google Scholar]
  18. Taub R. N., Lance E. M. Effects of lymphoid depletion on the distribution of 51Cr-labeled lymph node cells in mice. Transplantation. 1971 Jun;11(6):536–542. [PubMed] [Google Scholar]
  19. van der Werf-Messing B. Reticulum cell sarcoma and lymphosarcoma. A retrospective study of potential survival in loco-regional disease. Eur J Cancer. 1968 Dec;4(6):549–557. doi: 10.1016/0014-2964(68)90038-8. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES